Article citationsMore>>

Rook, G., Steele, J., Brealey, R., Whyte, A., Isenberg, D., Sumar, N., Nelson, J., Bodman, K., Young, A. and Roitt, I. (1991) Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. Journal of Autoimmunity, 4, 779-794. doi:10.1016/0896-8411(91)90173-A

has been cited by the following article:

• TITLE: Fc receptors: Cell activators of antibody functions

  AUTHORS: Carlos Rosales, Eileen Uribe-Querol

  KEYWORDS: Immunoglobulin; Antibody; Immunoreceptor; Neutrophil; Macrophage

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.4 No.4A, April 29, 2013

  ABSTRACT: At the onset of an infection early defense systems, such as complement, get into action. Specialized leukocytes (white blood cells) of the innate immune system, including monocytes, macrophages, and neutrophils also participate as a first line of defense against infections. These early responses are rapid but not very specific and are usually not enough to clear completely many infections. The adaptive immune system is also needed to finish the job against many microorganisms. Antibody molecules, produced during the adaptive immune response, are crucial for preventing recurrent infections. Although, IgG antibodies are essential for controlling infections, these molecules do not directly damage the microorganisms they recognize. Today, it is established that leukocytes of the innate immune system are responsible for the protective effects of these antibodies. IgG molecules bind to their cognate antigens and are in turn recognized by specific receptors (Fcγ receptors) on the membrane of leukocytes. Crosslinking these receptors on the surface of leukocytes leads to activation of several effector cell functions. These effector functions are geared toward the destruction of microbial pathogens and the induction of an inflammatory state that is beneficial during infections. However, in autoimmune diseases, antibodies can direct these effector functions against normal tissues and cause severe tissue damage. In recent years, several factors that can modulate the IgG-FcγR interaction have been elucidated. In this review, we describe the main types of Fcγ receptors, and our current view of how antibody variants interact with these receptors to initiate different cell responses. In addition, new findings on the signaling role of individual Fcγ receptors are also discussed.